Bayesian Capital Management’s Amyris Inc. AMRS Stock Holding History

Bayesian Capital Management’s Portfolio AMRS Stock Details AMRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75,200	Closed	-$102K	–	1143
2023 Q1	$102K	Buy	+75,200	New	+$107K	0.01%	683
2022 Q4	–	Sell	-43,845	Closed	-$128K	–	1096
2022 Q3	$128K	Buy	+43,845	New	+$120K	0.03%	569
2022 Q2	–	Sell	-51,900	Closed	-$226K	–	1170
2022 Q1	$226K	Buy	+51,900	New	+$233K	0.03%	616
2019 Q2	–	Sell	-31,300	Closed	-$65K	–	715
2019 Q1	$65K	Buy	+31,300	New	+$124K	0.01%	515
2018 Q3	–	Sell	-12,200	Closed	-$78K	–	844
2018 Q2	$78K	Sell	12,200 -1,000	-8%	-$6K	0.02%	565
2018 Q1	$88K	Buy	+13,200	New	+$70.8K	0.02%	534

Other funds holding AMRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bayesian Capital Management's AMRS Position: Q2 2023 in Review

Bayesian Capital Management sold out of Amyris Inc. (AMRS) in Q2 2023, closing a stake of 75,200 shares — an estimated $102K sold.

Bayesian Capital Management first reported a position in AMRS in Q1 2018 and held it in 6 quarters. The position peaked at $226K in Q1 2022. 155 funds tracked by Wall St. Rank hold AMRS as of Q2 2023.

Bayesian Capital Management reported no remaining Amyris Inc. position as of Q2 2023 after selling out during the quarter.
Bayesian Capital Management sold 75,200 Amyris Inc. shares in Q2 2023, an estimated $102K.
Bayesian Capital Management first reported a position in Amyris Inc. in Q1 2018 and held it in 6 quarters.
Bayesian Capital Management's Amyris Inc. position peaked at $226K in Q1 2022.
155 funds tracked by Wall St. Rank held Amyris Inc. as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.